Given the associations between faster post‐natal growth and greater obesity risk in childhood,9 it is essential to investigate the growth trajectories of metformin‐exposed children to determine whether they differ from those of insulin‐exposed children, according to growth period. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.